Association of soluble fms-like tyrosine kinase-1 with pulmonary hypertension and haemolysis in sickle cell disease

Kenneth I. Ataga, Julia Elizabeth Brittain, Susan K. Jones, Ryan May, John Delaney, Dell Strayhorn, Payal Desai, Rupa Redding-Lallinger, Nigel S. Key, Eugene P. Orringer

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The pathophysiology of pulmonary hypertension (PHT) in sickle cell disease (SCD) is probably multifactorial. Soluble fms-like tyrosine kinase-1 (sFLT-1) is a member of the vascular endothelial growth factor receptor (VEGFR) family. By adhering to and inhibiting VEGF and placenta growth factor, it induces endothelial dysfunction. We sought to evaluate the association of sFLT-1 with clinical complications of SCD. We confirmed that sFLT-1 was significantly elevated in SCD patients compared to healthy, race-matched control subjects. The level of sFLT-1 was significantly higher in patients with PHT, but no association was observed between sFLT-1 and the frequency of acute pain episodes or history of acute chest syndrome. sFLT-1 was correlated with various measures of haemolysis, erythropoietin and soluble vascular cell adhesion molecule-1. By inducing endothelial dysfunction, sFLT-1 may contribute to the pathogenesis of SCD-associated PHT, although this effect does not appear to be independent of haemolysis.

Original languageEnglish (US)
Pages (from-to)485-491
Number of pages7
JournalBritish Journal of Haematology
Volume152
Issue number4
DOIs
StatePublished - Feb 1 2011

Fingerprint

Vascular Endothelial Growth Factor Receptor-1
Sickle Cell Anemia
Hemolysis
Pulmonary Hypertension
Acute Chest Syndrome
Vascular Endothelial Growth Factor Receptor
Vascular Cell Adhesion Molecule-1
Acute Pain
Erythropoietin
Vascular Endothelial Growth Factor A

Keywords

  • Endothelial activation
  • Haemolysis
  • Pulmonary hypertension
  • Sickle cell disease
  • Soluble fms-like tyrosine kinase-1 (sFLT-1)

ASJC Scopus subject areas

  • Hematology

Cite this

Ataga, K. I., Brittain, J. E., Jones, S. K., May, R., Delaney, J., Strayhorn, D., ... Orringer, E. P. (2011). Association of soluble fms-like tyrosine kinase-1 with pulmonary hypertension and haemolysis in sickle cell disease. British Journal of Haematology, 152(4), 485-491. https://doi.org/10.1111/j.1365-2141.2010.08410.x

Association of soluble fms-like tyrosine kinase-1 with pulmonary hypertension and haemolysis in sickle cell disease. / Ataga, Kenneth I.; Brittain, Julia Elizabeth; Jones, Susan K.; May, Ryan; Delaney, John; Strayhorn, Dell; Desai, Payal; Redding-Lallinger, Rupa; Key, Nigel S.; Orringer, Eugene P.

In: British Journal of Haematology, Vol. 152, No. 4, 01.02.2011, p. 485-491.

Research output: Contribution to journalArticle

Ataga, KI, Brittain, JE, Jones, SK, May, R, Delaney, J, Strayhorn, D, Desai, P, Redding-Lallinger, R, Key, NS & Orringer, EP 2011, 'Association of soluble fms-like tyrosine kinase-1 with pulmonary hypertension and haemolysis in sickle cell disease', British Journal of Haematology, vol. 152, no. 4, pp. 485-491. https://doi.org/10.1111/j.1365-2141.2010.08410.x
Ataga, Kenneth I. ; Brittain, Julia Elizabeth ; Jones, Susan K. ; May, Ryan ; Delaney, John ; Strayhorn, Dell ; Desai, Payal ; Redding-Lallinger, Rupa ; Key, Nigel S. ; Orringer, Eugene P. / Association of soluble fms-like tyrosine kinase-1 with pulmonary hypertension and haemolysis in sickle cell disease. In: British Journal of Haematology. 2011 ; Vol. 152, No. 4. pp. 485-491.
@article{e60864f9331a462eabda2b7e4752df94,
title = "Association of soluble fms-like tyrosine kinase-1 with pulmonary hypertension and haemolysis in sickle cell disease",
abstract = "The pathophysiology of pulmonary hypertension (PHT) in sickle cell disease (SCD) is probably multifactorial. Soluble fms-like tyrosine kinase-1 (sFLT-1) is a member of the vascular endothelial growth factor receptor (VEGFR) family. By adhering to and inhibiting VEGF and placenta growth factor, it induces endothelial dysfunction. We sought to evaluate the association of sFLT-1 with clinical complications of SCD. We confirmed that sFLT-1 was significantly elevated in SCD patients compared to healthy, race-matched control subjects. The level of sFLT-1 was significantly higher in patients with PHT, but no association was observed between sFLT-1 and the frequency of acute pain episodes or history of acute chest syndrome. sFLT-1 was correlated with various measures of haemolysis, erythropoietin and soluble vascular cell adhesion molecule-1. By inducing endothelial dysfunction, sFLT-1 may contribute to the pathogenesis of SCD-associated PHT, although this effect does not appear to be independent of haemolysis.",
keywords = "Endothelial activation, Haemolysis, Pulmonary hypertension, Sickle cell disease, Soluble fms-like tyrosine kinase-1 (sFLT-1)",
author = "Ataga, {Kenneth I.} and Brittain, {Julia Elizabeth} and Jones, {Susan K.} and Ryan May and John Delaney and Dell Strayhorn and Payal Desai and Rupa Redding-Lallinger and Key, {Nigel S.} and Orringer, {Eugene P.}",
year = "2011",
month = "2",
day = "1",
doi = "10.1111/j.1365-2141.2010.08410.x",
language = "English (US)",
volume = "152",
pages = "485--491",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Association of soluble fms-like tyrosine kinase-1 with pulmonary hypertension and haemolysis in sickle cell disease

AU - Ataga, Kenneth I.

AU - Brittain, Julia Elizabeth

AU - Jones, Susan K.

AU - May, Ryan

AU - Delaney, John

AU - Strayhorn, Dell

AU - Desai, Payal

AU - Redding-Lallinger, Rupa

AU - Key, Nigel S.

AU - Orringer, Eugene P.

PY - 2011/2/1

Y1 - 2011/2/1

N2 - The pathophysiology of pulmonary hypertension (PHT) in sickle cell disease (SCD) is probably multifactorial. Soluble fms-like tyrosine kinase-1 (sFLT-1) is a member of the vascular endothelial growth factor receptor (VEGFR) family. By adhering to and inhibiting VEGF and placenta growth factor, it induces endothelial dysfunction. We sought to evaluate the association of sFLT-1 with clinical complications of SCD. We confirmed that sFLT-1 was significantly elevated in SCD patients compared to healthy, race-matched control subjects. The level of sFLT-1 was significantly higher in patients with PHT, but no association was observed between sFLT-1 and the frequency of acute pain episodes or history of acute chest syndrome. sFLT-1 was correlated with various measures of haemolysis, erythropoietin and soluble vascular cell adhesion molecule-1. By inducing endothelial dysfunction, sFLT-1 may contribute to the pathogenesis of SCD-associated PHT, although this effect does not appear to be independent of haemolysis.

AB - The pathophysiology of pulmonary hypertension (PHT) in sickle cell disease (SCD) is probably multifactorial. Soluble fms-like tyrosine kinase-1 (sFLT-1) is a member of the vascular endothelial growth factor receptor (VEGFR) family. By adhering to and inhibiting VEGF and placenta growth factor, it induces endothelial dysfunction. We sought to evaluate the association of sFLT-1 with clinical complications of SCD. We confirmed that sFLT-1 was significantly elevated in SCD patients compared to healthy, race-matched control subjects. The level of sFLT-1 was significantly higher in patients with PHT, but no association was observed between sFLT-1 and the frequency of acute pain episodes or history of acute chest syndrome. sFLT-1 was correlated with various measures of haemolysis, erythropoietin and soluble vascular cell adhesion molecule-1. By inducing endothelial dysfunction, sFLT-1 may contribute to the pathogenesis of SCD-associated PHT, although this effect does not appear to be independent of haemolysis.

KW - Endothelial activation

KW - Haemolysis

KW - Pulmonary hypertension

KW - Sickle cell disease

KW - Soluble fms-like tyrosine kinase-1 (sFLT-1)

UR - http://www.scopus.com/inward/record.url?scp=78851469125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78851469125&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2010.08410.x

DO - 10.1111/j.1365-2141.2010.08410.x

M3 - Article

C2 - 21223248

AN - SCOPUS:78851469125

VL - 152

SP - 485

EP - 491

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 4

ER -